[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100539899":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":18,"responsibleParty":35,"collaborators":7,"id":37,"slug":7,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},{"fullName":5,"class":6},"Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Ketty MD Peris","IRCCS FONDAZIONE POLICLINICO GEMELLI","PRINCIPAL_INVESTIGATOR",[14],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","0630154211","ketty.peris@unicatt.it",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Irccs Fondazione Policlinico Gemelli","RECRUITING","Roma","ITA","00168","Italy",{"type":27,"coordinates":28},"Point",[29,30],11.10642,44.99364,{"lat":30,"lon":29},[33],{"name":34,"role":15,"phone":16,"phoneExt":7,"email":17},"peris MD Peris",{"type":36,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100539899",false,"NCT06309836","Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma","REGISTRO-BCC","Inclusion Criteria:\n\n1. Male and female patients aged ≥ 18 years\n2. Patients diagnosed with advanced basal cell carcinoma of the skin, i.e. tumours included in at least one of the following categories: locally advanced carcinoma (not radically treatable by surgery and\u002For radiotherapy), carcinoma with lymph node and\u002For distant metastatic localisation\n3. patients who have had at least one access (first visit or follow-up visit) at the dermatology or oncology outpatient clinic of the centres involved\n\n   * Patients diagnosed with advanced BCC who have accessed the centre from 1 January 2016 until the date of activation of the centre will be included in the retrospective cohort;\n   * Patients diagnosed with advanced BCC who have accessed the centre from the date of activation\n4. Signature of informed consent\n\nExclusion Criteria:\n\nPatients incapable of giving informed consent","ALL","18 Years",{"count":46,"type":47},250,"ESTIMATED","OBSERVATIONAL","Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma.",[51],"Basal Cell Carcinoma","2025-06-09",{"date":54,"type":55},"2025-06-12","ACTUAL",{"date":57,"type":55},"2021-06-23",{"date":59,"type":47},"2029-12-31",{"name":5,"class":6},1]